About this Research Topic
Treatment Resistant Depression (TRD), in both unipolar and bipolar features, is a source of suffering for patients and a challenging topic for clinicians. Moreover, it has become time-consuming and financially impactful for health systems. TRD prevalence may vary among different countries and in different sample studies ranging from 30- to 40 % of patients treated with antidepressants; less is known about resistance in bipolar depression that may be further more pervasive and difficult to treat. Treatment-resistance is impactful for patients, caregivers and families, increasing disability and worsening quality of life. Treatment options may vary from traditional association and augmentations strategies to psychotherapy and to brain stimulation therapies (ECT, TMS, VNS). Recently, new pharmacological approaches have been developed focusing on psychedelic-derived drugs (ketamine, esketamine, psylocibin), providing clinicians with new treatment choices.
The aim of this Research Topic is to collect recent advances in TRD field from clinical, epidemiological, quality of life and burden aspects to traditional and novel treatment strategies. Original Research, Review, Case Reports, Perspective and Hypothesis & Theory studies are welcomed on the following topics:
- Clinical definition and characterization of unipolar and/or bipolar TRD
- Epidemiological data, patients quality of life and family burden, health care costs of unipolar and/or bipolar TRD
- TRD pharmacological treatment options, ranging from traditional strategies to novel psychedelic-derived drug approaches (ketamine, esketamine, psylocibin)
- Psychotherapy interventions
- Brain Stimulating Therapies (ECT, TMS, VNS)
These may considered only examples of desirable papers welcome in this research topic, but every type of contribution aiming to the characterization and clarification of TRD in its multiple aspects is welcome.
The aim of this Research Topic is to collect recent advances in TRD field from clinical, epidemiological, quality of life and burden aspects to traditional and novel treatment strategies. Original Research, Review, Case Reports, Perspective and Hypothesis & Theory studies are welcomed on the following topics:
- Clinical definition and characterization of unipolar and/or bipolar TRD
- Epidemiological data, patients quality of life and family burden, health care costs of unipolar and/or bipolar TRD
- TRD pharmacological treatment options, ranging from traditional strategies to novel psychedelic-derived drug approaches (ketamine, esketamine, psylocibin)
- Psychotherapy interventions
- Brain Stimulating Therapies (ECT, TMS, VNS)
These may considered only examples of desirable papers welcome in this research topic, but every type of contribution aiming to the characterization and clarification of TRD in its multiple aspects is welcome.
Keywords: TRD, depression, treatment, epidemiology, clinic, burden, major depressive disorder, bipolar depression
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
